Search

Your search keyword '"Prostaglandin E receptor 3"' showing total 105 results

Search Constraints

Start Over You searched for: Descriptor "Prostaglandin E receptor 3" Remove constraint Descriptor: "Prostaglandin E receptor 3"
105 results on '"Prostaglandin E receptor 3"'

Search Results

2. Prostaglandin E2 and F2α Alter Expression of Select Cholesteryl Esters and Triacylglycerols Produced by Human Meibomian Gland Epithelial Cells

3. Discovery of a Novel Series of Pyridone-Based EP3 Antagonists for the Treatment of Type 2 Diabetes

4. The use of social media platform to promote authentic learning environment in higher education setting

5. The rice EP3 and OsFBK1 E3 ligases alter plant architecture and flower development, and affect transcript accumulation of microRNA pathway genes and their targets

6. Actinidia chinensis Planch root extract (acRoots) inhibits hepatocellular carcinoma progression by inhibiting EP3 expression.

7. Correction to: The BDF3/EP3 Scheme for MBE with No Slope Selection is Stable

8. Systems approach reveals distinct and shared signaling networks of the four PGE2 receptors in T cells

9. Prostaglandin E2sequentially activates E‐prostanoid receptor‐3 and thromboxane prostanoid receptor to evoke contraction and increase in resistance of the mouse renal vasculature

10. CSIG-15. INNOVATIVE COMPUTATIONAL PLATFORM ADDRESSES PROSTAGLANDIN E RECEPTOR 3 AS THE MASTER REGULATOR MEDIATING RESISTANCE TO TUMOR TREATING FIELDS IN GLIOBLASTOMA CELLS

11. EP3 Is an Independent Prognostic Marker Only for Unifocal Breast Cancer Cases

12. Prostaglandin E2 EP receptors in cardiovascular disease: An update

13. DDRE-13. PROSTAGLANDIN E RECEPTOR 3 (PTGER3) REGULATES RESISTANCE TO TUMOR TREATING FIELDS (TTFields) IN GLIOBLASTOMA CELLS

14. Optimization of physicochemical properties of pyridone-based EP3 receptor antagonists

15. DRES-06. PROSTAGLANDIN E RECEPTOR 3 MEDIATES RESISTANCE TO TUMOR TREATING FIELDS IN GLIOBLASTOMA CELLS

16. Improving Magnetic Properties of BiFeO3-BaFe12O19 Solid Solution by Different Sintering Time and Temperatures of Sol-Gel Method

17. Role of the heterotrimeric inhibitory G‐protein, Gαz, and its unique G‐protein coupled receptor, EP3, in the progression and pathophysiology of Type 2 Diabetes

18. Discovery of Novel Seven-Membered Prostacyclin Analogues as Potent and Selective Prostaglandin FP and EP3 Dual Agonists

19. Ocular hypotensive effect of the novel EP3/FP agonist ONO-9054 versus Xalatan: results of a 28-day, double-masked, randomised study

20. Cold medicine-related Stevens–Johnson syndrome/toxic epidermal necrolysis with severe ocular complications—phenotypes and genetic predispositions

21. The influence of prostaglandin E2 on the production of IFN-γ by bovine CD4+, CD8+ and WC1+ T cells

22. Novel pyridone EP4 agonists featuring allylic alcohol ω-chains

23. The role of EP3-receptor expression in cervical dysplasia

24. Combination of UVB Absorbing Titanium Dioxide and Quercetin Nanogel for Skin Cancer Chemoprevention

27. Advances in extracellular ligand recognition sites on prostanoid receptors

29. The Vertical Forces Introduced by Wind on the Active Pantograph from Bodywork of Locomotive LE 060 EA of 5100 kW

30. Considerations on Dynamic Contact Force with Catenary for the EP3 Pantograph

31. Up-regulation of Cyclooxygenase-2 (COX-2) and Prostaglandin E2 receptor 3 (EP3) in the decidua of patients with unexplained recurrent pregnancy losses (RPL)

34. Effect ofCarica papayaL. Stem Bark Extracts on Cholesterol Concentration in Rats Induced with Streptosozin

35. Can ear postures reliably measure the positive emotional state of cows?

36. Effects of Feed Rate and Screw Speed of Extruded Diets on Growth and Body Composition of Olive Flounder Paralichthys olivaceus

38. Characteristics and Flocculating Mechanism of a Bioflocculant M-1 Produced by Enterobacter sp. EP3

39. Use of effect pigments for quality enhancement of offset printed specialty papers

40. Stress responses: the contribution of prostaglandin E(2) and its receptors

41. Suppression of polyI:C-inducible gene expression by EP3 in murine conjunctival epithelium

42. Experimental investigation of low-velocity impact characteristics of woven glass fiber epoxy matrix composite laminates of EP3 grade

43. Generation, Validation, and Utilization of a Three-Dimensional Pharmacophore Model for EP3 Antagonists

44. PGE2-EP3 signaling exacerbates intracerebral hemorrhage outcomes in 24-mo-old mice

45. HLA-A*02:06 and PTGER3 polymorphism exert additive effects in cold medicine-related Stevens–Johnson syndrome with severe ocular complications

46. Secretion of a chitinase-like protein in embryogenic suspension cultures of Dactylis glomerata L

47. Age-Induced Reprogramming of Mast Cell Degranulation

48. Two new Antarctic stegocephalid (Amphipoda: Stegocephalidae: Stegocephalinae) species, with implications for the phylogeny and classification of the two genera Pseudo and Schellenbergia

49. Bonding isomerism in the η1-P coordination of the P4X3 (X=S, Se) molecules toward 16e rhodium fragments stabilized by tripodal tetradentate ligands

50. EP3: Innovating on the tapeout treadmill

Catalog

Books, media, physical & digital resources